Pages that link to "Q34583647"

The following pages link to Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer (Q34583647):

Displaying 48 items.

• Understanding cachexia as a cancer metabolism syndrome (Q28069390) (← links)
• The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established Concepts (Q28078802) (← links)
• The Peter Brojde lung cancer centre: a model of integrative practice (Q30417605) (← links)
• Fish consumption and the risk of gastric cancer: systematic review and meta-analysis (Q33797408) (← links)
• Lung cancer survival with herbal medicine and vitamins in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods (Q33985493) (← links)
• Cancer cachexia: medical management (Q34018994) (← links)
• A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients--ACCeRT study (Q34082057) (← links)
• Treatment of cachexia in oncology (Q34158188) (← links)
• Dietary sources of omega 3 fatty acids: public health risks and benefits (Q34275377) (← links)
• Why and How Meet n-3 PUFA Dietary Recommendations? (Q34416842) (← links)
• Optimal management of cancer anorexia-cachexia syndrome. (Q34417908) (← links)
• Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: a systematic review (Q34636946) (← links)
• Cancer cachexia, mechanism and treatment (Q34669440) (← links)
• The association between fish consumption and risk of renal cancer: a meta-analysis of observational studies (Q35060811) (← links)
• Cancer cachexia update in head and neck cancer: Pathophysiology and treatment. (Q35122201) (← links)
• Fish intake and ovarian cancer risk: a meta-analysis of 15 case-control and cohort studies (Q35147528) (← links)
• Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation (Q35389104) (← links)
• Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia (Q35583902) (← links)
• Fish consumption doesn't reduce the risk of hepatocellular carcinoma. (Q35778891) (← links)
• Skeletal muscle atrophy is attenuated in tumor-bearing mice under chemotherapy by treatment with fish oil and selenium (Q35781409) (← links)
• Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors (Q35925247) (← links)
• Seafood consumption and components for health (Q36648133) (← links)
• Marine polyunsaturated fatty acids and cancer therapy (Q36671846) (← links)
• Multi-targeted therapy of cancer by omega-3 fatty acids (Q36947010) (← links)
• Exercise and nutrition interventions in advanced lung cancer: a systematic review. (Q37056898) (← links)
• Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome (Q37103603) (← links)
• Muscle function and omega-3 fatty acids in the prediction of lean body mass after breast cancer treatment (Q37439648) (← links)
• Nutrition aspects of lung cancer (Q37643139) (← links)
• Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review (Q38047351) (← links)
• Current pharmacotherapy options for cancer anorexia and cachexia (Q38052613) (← links)
• Omega-3 fatty acids and changes in LBM: alone or in synergy for better muscle health? (Q38112812) (← links)
• The consumption of omega-3 polyunsaturated fatty acids improves clinical outcomes and prognosis in pancreatic cancer patients: a systematic evaluation (Q38271488) (← links)
• Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials. (Q38557891) (← links)
• The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders. (Q38574561) (← links)
• Advances in pharmacologic strategies for cancer cachexia (Q38578582) (← links)
• Nutritional screening and early treatment of malnutrition in cancer patients (Q42117487) (← links)
• Fish oil inhibits human lung carcinoma cell growth by suppressing integrin-linked kinase (Q43154325) (← links)
• Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia (Q43267355) (← links)
• Relationship between weakness and phase angle in advanced cancer patients with fatigue (Q46363436) (← links)
• Weight loss in cancer patients: a plea for a better awareness of the issue. (Q47397575) (← links)
• Very long-chain n-3 fatty acids and human health: fact, fiction and the future (Q47642249) (← links)
• Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. (Q51666888) (← links)
• Omega-3 fatty acids, membrane remodeling and cancer prevention. (Q52329039) (← links)
• Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis. (Q52714644) (← links)
• Omega-3 fatty acid concentrate from Dunaliella salina possesses anti-inflammatory properties including blockade of NF-κB nuclear translocation. (Q54185338) (← links)
• Effect of omega 3 fatty acids on C-reactive protein and interleukin-6 in patients with advanced nonsmall cell lung cancer (Q58739721) (← links)
• Multicenter Randomized Controlled Trial of Omega-3 Fatty Acids Versus Omega-6 Fatty Acids for the Control of Cancer-Related Fatigue Among Breast Cancer Survivors (Q64120272) (← links)
• Fish oil supplementation improves neutrophil function during cancer chemotherapy (Q82907801) (← links)